Table 1 A Summary of the ASA Desensitization Regimens Used in Our 3 Patients
Case | Clinical Manifestations of ASA Hypersensitivity | Premedication | Initial ASA Dose (mg)* | Final ASA Dose (mg) | Initial Dosing Interval (minutes) | Time to Achieve a Single Daily Dose of 100 mg of ASA (days) | Breakthrough Reactions (on Maintenance Dosage After Final Protocol Given) | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|
1 | Angioedema/urticaria | Fexofenadine | 0.0001 | 100 | 30 | 10 | No | 8 |
2 | Urticaria | Fexofenadine | 10 | 100 | 90 | 6 | No | 6 |
3 | Urticaria | Fexofenadine | 10 | 100 | 90 | 6 | No | 3 |